PRVA Company Profile and Key Details

Q: Who are the executives of PRVA?

Mr. Thomas BartrumExecutive Vice President & Gen. CounselMr. Chris VoigtExecutive Vice President & Chief Technology OfficerMs. Dana Fields CPASenior Vice President of Internal Audit & Chief Compliance OfficerMr. Robert P. BorchertSenior Vice President of Investor Relations & Corporation CommunicationsMr. Jay StevensSenior Vice President & Chief Growth OfficerMr. Eric J. BeyerExecutive Vice President of Medical GroupsMr. Parth MehrotraChief Executive Officer & DirectorMr. Matthew Shawn MorrisChief Executive Officer & DirectorMr. David Mountcastle CPA, MBAExecutive Vice President, Chief Financial Officer & Principal Accounting OfficerMs. Jenny HardingSenior Vice President of People OperationsDr. Jim Sams M.D.Chief Executive Officer of Privia Medical Group - Georgia & Physician Executive of Privia Medical Group - TennesseeDr. S. Mark Cone FACOG, M.D.Pres of Privia Medical Group - Gulf Coast Texas

NASDAQ : PRVA

Privia Health Group

$23.55

0.11+0.47%

Open: 12:03 PM

71.73

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Privia Health Group, Inc. (PRVA) stock surged +0.47%, trading at $23.55 on NASDAQ, up from the previous close of $23.44. The stock opened at $23.47, fluctuating between $23.36 and $23.71 in the recent session.

Stock Snapshot

23.44

Prev. Close

2.91B

Market Cap

23.36

Day Low

130.83

P/E Ratio

0.18

EPS (TTM)

0.71

Cash Flow per Share

23.47

Open

123.69M

Number of Shares

23.705

Day High

80.42%

Free Float in %

4.75

Book Value

218.76K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 14, 2026	23.01	23.48	22.95	23.12	501.5K
Apr 13, 2026	22.30	23.02	22.15	23.01	819.76K
Apr 10, 2026	22.70	22.71	22.25	22.37	875.84K
Apr 09, 2026	22.65	22.96	22.44	22.71	1.14M
Apr 08, 2026	22.87	22.98	22.59	22.71	1.25M
Apr 07, 2026	21.76	22.48	21.54	22.38	782.29K
Apr 06, 2026	21.14	21.68	20.40	21.59	900.83K
Apr 02, 2026	20.68	21.23	20.41	21.21	723.72K
Apr 01, 2026	20.46	21.18	20.36	21.07	863.99K
Mar 31, 2026	20.26	20.73	20.07	20.57	824.39K
Mar 30, 2026	20.18	20.28	19.86	20.02	791.84K
Mar 27, 2026	19.97	20.15	19.53	20.02	955.26K
Mar 25, 2026	21.28	21.40	20.23	20.54	595.62K
Mar 24, 2026	21.24	21.24	20.85	21.03	700.49K
Mar 23, 2026	21.72	21.87	21.30	21.52	773.42K
Mar 20, 2026	21.73	21.80	20.99	21.24	1.74M
Mar 19, 2026	21.54	22.00	21.27	21.77	756.95K
Mar 18, 2026	21.82	21.98	21.56	21.59	1.11M
Mar 17, 2026	22.09	22.50	21.83	22.10	557.82K
Mar 16, 2026	21.85	22.28	21.84	21.96	633.32K

Contact Details

Arlington, VA 22203

United States

https://www.priviahealth.com 571 366 8850

About Company

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. was a former subsidiary of Brighton Health Group Holdings, LLC.

Stock Peers

BTSGU

-0.13-0.08%

BrightSpring Health Services, Inc. Tangible Equity Unit$153.75 NUTX

1.57+1.48%

Nutex Health, Inc.$107.84 HQY

1.45+1.81%

HealthEquity, Inc.$81.36 GEHC

0.84+1.14%

GE HealthCare Technologies Inc.$74.67 WGS

5.88+9.64%

GeneDx Holdings Corp.$66.86 TEM

3.55+7.72%

Tempus AI, Inc.$49.53 BTSG

0.01+0.02%

BrightSpring Health Services, Inc. Common Stock$46.04 OMCL

1.32+3.77%

Omnicell, Inc.$36.33 HTFL

1.62+5.91%

Heartflow, Inc. Common Stock$29.05 PINC

0.09+0.32%

Premier, Inc.$28.26

Company Overview

Privia Health Group, Inc. (NASDAQ:PRVA) closed at $23.55 USD, gaining $0.11 (0.47%) from the previous close of $23.44. The stock is currently mid-range between its 52-week high and low $18.77 and $26.51. With a market capitalization of about $2.91 billion, Privia Health Group, Inc. is classified as a mid-cap and shows market-like volatility (beta ~0.87). Key stats such as the average daily volume over the past year has been around 862.47 thousand shares, volume is running light vs its 52-week average. Headquartered in Arlington, VA, Privia Health Group, Inc. operates in the Healthcare sector and the Medical - Healthcare Information Services industry. Led by CEO Parth Mehrotra, the company employs approximately 1,140 people and listed since April 28, 2021. Privia Health Group, Inc. operates as a national physician-enablement company in the United States.

Technical Performance

PRVA has shown mixed momentum, losing -0.9% over the past week and -9.09% over the past quarter, though year-to-date performance is down -2.11%. Short-term trend indicators are mixed aligned (SMA20 12.0%, SMA50 7.85%, SMA200 8.57%). The stock’s 14-day RSI is 67.32 (firm momentum), while the ATR of 0.97 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -6.04% below its high and over 32.71% above its low. Average 10-day trading volume of 895.48 thousand shares is in line with the 3-month average of 844.02 thousand, indicating normal recent market interest.

Valuation Metrics

Privia Health Group, Inc. trades at a P/E ratio of 123.69, slightly above the S&P 500 average, with a price-to-sales ratio of 1.34 and a price-to-book ratio of 3.85 trading at moderately above to book value. The P/FCF stands at 17.55, also above market averages.

Dividend & Fair Value

Privia Health Group, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $51.13. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Privia Health Group, Inc. generated EPS of $0.14 over the past year. Five-year average earnings growth is 7.98%. Wall Street analysts project EPS growth of 43.25% annually over the next five years. The latest quarter delivered EPS of $0.05. The next quarter is forecast at $0.02. Next year's EPS is expected at $42.12. Analyst sentiment is bullish. Analyst rating data shows there are 12 Strong Buy ratings, 5 Buy ratings, 3 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $35.00 to $22.00. The high target offers 51.38% upside. The low target suggests -4.84% downside. The mean target is $30.35. This offers 31.27% upside. Privia Health Group, Inc. earnings surprise history is frequent misses against expectations. The quarter that ended November 06, 2025, missed forecasts by -16.67%. The prior quarter beat by -60.0%. Over the last six quarters, Apple has recorded several small beats. These include -44.66% in August 08, 2024.

Shareholding & Insider Activity

Privia Health Group, Inc. has 122.73 million shares outstanding. The public float is 98.70 million shares, elevated short interest at 4.82% of float. This equals 3.28 million shares. The short ratio is 3.12 days. Institutional investors hold 104.45% of the float. Insiders own 7.08%. Boehler Adam holds 5.77 million shares, Sullivan William M has 5.45 million shares and Mehrotra Parth has 555.44 thousand shares. Over the past six months, insider transactions show net selling. They sold 262.16 thousand shares across 20 transactions.

Financial & Profitability Overview

Over the trailing twelve months, Privia Health Group generated $1.66B in revenue, or $13.30 per share. Gross margin was 9.35%, operating margin 1.25%, and net profit margin 1.39%. Returns are modest, with ROA at 2.31% and ROE at 4.11%.
On valuation metrics, Privia Health Group trades at a P/E of 123.69, P/S of 1.34 and P/B of 3.85. The current ratio is 1.60 and quick ratio is 1.60. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is 67.41 days. Debt-to-equity is 0.01, supported by a cash flow-to-debt ratio of 17.14.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, Privia Health Group posted revenue of $1.66B, down slightly from $1.36B in the prior quarter. Gross profit was $154.97M (margin 9.35%). Operating income was $20.65M (margin 1.2%). Net income was$23.08M (EPS $0.20).
The company ended the quarter with $389.51M in cash and short-term investments, a total debt of $8.29M, and net debt of - $381.22M. Total assets were $999.90M, with equity of $607.39M. Financials further reflected stability, with operating cash flow of $84.00M, free cash flow of $83.89M, and capital expenditures of - $113.00K.

Price Forecast & Outlook

Our AI price prediction model suggests that Privia Health Group, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 0.09%, with price expected at $23.14 by April 28, 2026, within a range of $21.99 to $24.32 3-Month Outlook: Projected fall of -23.79%, reaching $17.62 by July 13, 2026, with a range of $17.19 to $18.03. 1-Year Outlook: Projected loss of -0.95%, with price at $22.90 by April 14, 2027, within a range of $21.85 to $24.11.

Key Takeaways

Privia Health Group, Inc. (NASDAQ:PRVA) shares are flat -2.11% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Privia Health Group, Inc. trading at a premium to the broader market with a P/E of 123.69. Analyst sentiment is bullish, with the majority of ratings in Outperform territory and a mean price target of $31.44, suggesting 35.99% upside. Our AI forecast model points to short-term strength (0.09% over two weeks), a medium-term fall (-23.79% over three months), and a longer-term loss (-0.95% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Privia Health Group, Inc. (PRVA) stock price?

Privia Health Group, Inc. (NASDAQ: PRVA) stock price is $23.55 in the last trading session. During the trading session, PRVA stock reached the peak price of $23.71 while $23.36 was the lowest point it dropped to. The percentage change in PRVA stock occurred in the recent session was 0.47% while the dollar amount for the price change in PRVA stock was $0.11.

PRVA's industry and sector of operation?

The NASDAQ listed PRVA is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector. Privia Health Group, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of PRVA?

Mr. Thomas Bartrum
Executive Vice President & Gen. Counsel
Mr. Chris Voigt
Executive Vice President & Chief Technology Officer
Ms. Dana Fields CPA
Senior Vice President of Internal Audit & Chief Compliance Officer
Mr. Robert P. Borchert
Senior Vice President of Investor Relations & Corporation Communications
Mr. Jay Stevens
Senior Vice President & Chief Growth Officer
Mr. Eric J. Beyer
Executive Vice President of Medical Groups
Mr. Parth Mehrotra
Chief Executive Officer & Director
Mr. Matthew Shawn Morris
Chief Executive Officer & Director
Mr. David Mountcastle CPA, MBA
Executive Vice President, Chief Financial Officer & Principal Accounting Officer
Ms. Jenny Harding
Senior Vice President of People Operations
Dr. Jim Sams M.D.
Chief Executive Officer of Privia Medical Group - Georgia & Physician Executive of Privia Medical Group - Tennessee
Dr. S. Mark Cone FACOG, M.D.
Pres of Privia Medical Group - Gulf Coast Texas

How PRVA did perform over past 52-week?

PRVA's closing price is 23.18% higher than its 52-week low of $18.77 where as its distance from 52-week high of $26.51 is -12.79%.

How many employees does PRVA have?

Number of PRVA employees currently stands at 1,140.

Link for PRVA official website?

Official Website of PRVA is: https://www.priviahealth.com

How do I contact PRVA?

PRVA could be contacted at phone 571 366 8850 and can also be accessed through its website. PRVA operates from 950 North Glebe Road, Arlington, VA 22203, United States.

How many shares of PRVA are traded daily?

PRVA stock volume for the day was 218.76K shares. The average number of PRVA shares traded daily for last 3 months was 862.47K.

What is the market cap of PRVA currently?

The market value of PRVA currently stands at $2.91B with its latest stock price at $23.55 and 123.69M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	1140
Beta	0.82
Sales or Revenue	$1.66B
5Y Sales Change%	1.22%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Healthcare Information Services

PRVA Company Profile and Key Details

Privia Health Group

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Shareholding & Insider Activity

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Technical Performance

Company Overview

Earnings & Analyst Outlook

Valuation Metrics

Price Forecast & Outlook

Key Takeaways